| Authors: |
Tuit S; Genomics and Immunoregulation, LIMES Institute, University of Bonn, 53113 Bonn, Germany; Department of Anatomy and Embryology, Leiden University Medical Center, 2333 ZC Leiden, the Netherlands., Salvagno C; Division of Tumor Biology & Immunology, Oncode Institute, the Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands., Kapellos TS; Genomics and Immunoregulation, LIMES Institute, University of Bonn, 53113 Bonn, Germany., Hau CS; Division of Tumor Biology & Immunology, Oncode Institute, the Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands., Seep L; Genomics and Immunoregulation, LIMES Institute, University of Bonn, 53113 Bonn, Germany., Oestreich M; Genomics and Immunoregulation, LIMES Institute, University of Bonn, 53113 Bonn, Germany., Klee K; Genomics and Immunoregulation, LIMES Institute, University of Bonn, 53113 Bonn, Germany., de Visser KE; Division of Tumor Biology & Immunology, Oncode Institute, the Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands. Electronic address: k.d.visser@nki.nl., Ulas T; Genomics and Immunoregulation, LIMES Institute, University of Bonn, 53113 Bonn, Germany., Schultze JL; Genomics and Immunoregulation, LIMES Institute, University of Bonn, 53113 Bonn, Germany; Platform for Single Cell Genomics and Epigenomics (PRECISE) at the German Center for Neurodegenerative Diseases and the University of Bonn, 53127 Bonn, Germany. Electronic address: j.schultze@uni-bonn.de. |
